General Info

VIVUS is a pharmaceutical company focused on the development and commercialization of new therapeutic products addressing obesity and sexual health, having its facilities in Mountain View, Calif. VIVUS has four products that are positioned to enter Phase 3 clinical trials, and one product that has completed Phase 3 evaluation, for which a new drug application has been submitted to the Food and Drug Administration. The pipeline includes QnexaTM, for which a Phase 2 study has been completed for the treatment of obesity, ALISTATM, for which a Phase 2B program is ongoing for the treatment of female sexual arousal disorder. Other products under development include Testosterone MDTS, for which a Phase 2 program has been completed for the treatment of hypoactive sexual desire disorder, and EvamistTM, for which a Phase 3 program has been completed for the treatment of menopausal symptoms. VIVUS has also developed and is marketing MUSE, a treatment for erectile dysfunction.